141 related articles for article (PubMed ID: 10882843)
21. Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean schizophrenics.
Woo SI; Kim JW; Rha E; Han SH; Hahn KH; Park CS; Sohn JW
Psychiatry Clin Neurosci; 2002 Aug; 56(4):469-74. PubMed ID: 12109967
[TBL] [Abstract][Full Text] [Related]
22. Mn-superoxide dismutase activity is associated with orofacial involuntary movements in schizophrenia patients with tardive dyskinesia.
Wu JQ; Chen DC; Tan YL; Soares JC; Zhang XY
Hum Psychopharmacol; 2015 Jan; 30(1):57-63. PubMed ID: 25572310
[TBL] [Abstract][Full Text] [Related]
23. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.
Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Mukit SR; Shriharsh V; Lerer B; Nimagaonkar VL; Thelma BK
Pharmacogenomics J; 2005; 5(1):60-9. PubMed ID: 15505641
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein E epsilon4 and tardive dyskinesia in a Japanese population.
Kimura T; Shono M; Yokota S; Ishizuka K; Watanabe M; Takamatsu J; Miyakawa T
J Psychiatr Res; 2000; 34(4-5):329-32. PubMed ID: 11104846
[TBL] [Abstract][Full Text] [Related]
25. Manganese superoxide dismutase (MnSOD) gene (Ala-9Val, Ile58Thr) polymorphism in patients with age-related macular degeneration (AMD).
Kowalski M; Bielecka-Kowalska A; Oszajca K; Eusebio M; Jaworski P; Bartkowiak J; Szemraj J
Med Sci Monit; 2010 Apr; 16(4):CR190-196. PubMed ID: 20357718
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism.
Lerer B; Segman RH; Fangerau H; Daly AK; Basile VS; Cavallaro R; Aschauer HN; McCreadie RG; Ohlraun S; Ferrier N; Masellis M; Verga M; Scharfetter J; Rietschel M; Lovlie R; Levy UH; Meltzer HY; Kennedy JL; Steen VM; Macciardi F
Neuropsychopharmacology; 2002 Jul; 27(1):105-19. PubMed ID: 12062911
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.
Matsumoto C; Shinkai T; Hori H; Ohmori O; Nakamura J
Psychiatry Res; 2004 Jun; 127(1-2):1-7. PubMed ID: 15261699
[TBL] [Abstract][Full Text] [Related]
28. No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients.
Kang SG; Choi JE; An H; Lim SW; Lee HJ; Han C; Kim YK; Kim SH; Cho SN; Lee MS; Joe SH; Jung IK; Kim L
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1545-8. PubMed ID: 18602732
[TBL] [Abstract][Full Text] [Related]
29. No evidence for an association between G protein beta3 subunit gene C825T polymorphism and tardive dyskinesia in schizophrenia.
Lee HJ; Kang SG; Paik JW; Lee MS; Cho BH; Park YM; Kim W; Choi JE; Jung IK; Kim L; Lee MS
Hum Psychopharmacol; 2007 Dec; 22(8):501-4. PubMed ID: 17726725
[TBL] [Abstract][Full Text] [Related]
30. Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism.
Tiwari AK; Deshpande SN; Lerer B; Nimgaonkar VL; Thelma BK
Pharmacogenomics J; 2007 Oct; 7(5):305-11. PubMed ID: 16969362
[TBL] [Abstract][Full Text] [Related]
31. Tardive dyskinesia and debrisoquine 4-hydroxylase (CYP2D6) genotype in Japanese schizophrenics.
Ohmori O; Suzuki T; Kojima H; Shinkai T; Terao T; Mita T; Abe K
Schizophr Res; 1998 Jul; 32(2):107-13. PubMed ID: 9713906
[TBL] [Abstract][Full Text] [Related]
32. Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk - A meta-analysis.
Wang S; Wang F; Shi X; Dai J; Peng Y; Guo X; Wang X; Shen H; Hu Z
Eur J Cancer; 2009 Nov; 45(16):2874-81. PubMed ID: 19467856
[TBL] [Abstract][Full Text] [Related]
33. Association between three functional polymorphisms of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia.
Hori H; Ohmori O; Shinkai T; Kojima H; Nakamura J
Am J Med Genet; 2001 Dec; 105(8):774-8. PubMed ID: 11803529
[TBL] [Abstract][Full Text] [Related]
34. Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesia.
Shinkai T; De Luca V; Hwang R; Matsumoto C; Hori H; Ohmori O; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Nakamura J; Kennedy JL
Neurosci Lett; 2005 Nov; 388(2):116-20. PubMed ID: 16039055
[TBL] [Abstract][Full Text] [Related]
35. Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and tardive dyskinesia in patients with schizophrenia.
Liou YJ; Lai IC; Lin MW; Bai YM; Lin CC; Liao DL; Chen JY; Lin CY; Wang YC
Pharmacogenet Genomics; 2006 Mar; 16(3):151-7. PubMed ID: 16495774
[TBL] [Abstract][Full Text] [Related]
36. Cognitive function, plasma MnSOD activity, and MnSOD Ala-9Val polymorphism in patients with schizophrenia and normal controls.
Zhang XY; Chen DC; Xiu MH; Yang FD; Tan Y; Luo X; Zuo L; Kosten TA; Kosten TR
Schizophr Bull; 2014 May; 40(3):592-601. PubMed ID: 23588476
[TBL] [Abstract][Full Text] [Related]
37. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B
Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227
[TBL] [Abstract][Full Text] [Related]
38. Genetic polymorphism of manganese superoxide dismutase (MnSOD) and breast cancer susceptibility.
Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Elhan AH; Karakaya AE
Cell Biochem Funct; 2005; 23(1):73-6. PubMed ID: 15386537
[TBL] [Abstract][Full Text] [Related]
39. No association between dopamine D4 receptor gene -521 C/T polymorphism and tardive dyskinesia in schizophrenia.
Lee HJ; Kang SG; Choi JE; Paik JW; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
Neuropsychobiology; 2007; 55(1):47-51. PubMed ID: 17556853
[TBL] [Abstract][Full Text] [Related]
40. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.
Lohmann PL; Bagli M; Krauss H; Müller DJ; Schulze TG; Fangerau H; Ludwig M; Barkow K; Held T; Heun R; Maier W; Rietschel M; Rao ML
Pharmacopsychiatry; 2003; 36(2):73-8. PubMed ID: 12734765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
